NNNN
Anbio Biotechnology
NASDAQ · Healthcare · Medical - Instruments & Supplies · DE
$3.72
+0.00%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.26x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- -1.20x
Liquidity & coverage
- Current ratio
- 344.31x
- Quick ratio
- 344.31x
- Cash ratio
- 135.49x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $30.2M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025